Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$26.14−0.21 (-0.80%)
Close on Nov 13, 2026Market cap $1.00BP/E –Yield –
Ceribell total assets
Total assets on the balance sheet at the end of each period.
Ceribell's total assets was $166.35M at Jun 30, 2026. For fiscal 2025 it was $195.80M, down 13.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $195.80M | -13.1% |
| FY2024 | Dec 31, 2024 | $225.41M | +282.6% |
| FY2023 | Dec 31, 2023 | $58.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $166.35M | -19.9% |
| Q1 FY2026 | Mar 31, 2026 | $178.08M | -16.6% |
| Q4 FY2025 | Dec 31, 2025 | $195.80M | -13.1% |
| Q3 FY2025 | Sep 30, 2025 | $199.53M | +324.0% |
| Q2 FY2025 | Jun 30, 2025 | $207.69M | +252.5% |
| Q1 FY2025 | Mar 31, 2025 | $213.47M | – |
| Q4 FY2024 | Dec 31, 2024 | $225.41M | – |
| Q3 FY2024 | Sep 30, 2024 | $47.06M | – |
| Q4 FY2023 | Dec 31, 2023 | $58.92M | – |
See a number that looks wrong?